Table 1.
Clinical characteristic of the 52 included patients.
| Clinical Characteristics | Study Population (n = 52) |
|---|---|
| Female, n (%) | 29 (56%) |
| Ancestry, n (%) | |
| European | 5 (9.6%) |
| Sub-Saharan Africa/Caribbean | 37 (71.15%) |
| North African | 9 (17.3%) |
| India | 1 (1.9%) |
| Age at diagnosis, in years, mean ± SD (rv) | 12.03 ± 2.715 (5; 15) |
| Age at the last evaluation, in years, median (Q1–Q3) | 23.6 (19.25–26.48) |
| Length of follow-up, in years, median (Q1–Q3) | 11.48 (6.48;14.5) |
| Delayed diagnosed comorbidity, n (%) | |
| Crohn disease | 2 (3.8%) |
| Acquired hemophilia | 1 (1.9%) |
| Immune thrombocytopenia | 1 (1.9%) |
| Hemochromatosis | 1 (1.9%) |
| Idiopathic hemophagocytic lymphohistiocytosis | 1 (1.9%) |
SD: standard deviation, rv: range values, Q1: first quartile, Q3: third quartile.